<DOC>
	<DOCNO>NCT02674399</DOCNO>
	<brief_summary>This study double-blind , randomize , control study two arm evaluate JointStem treatment subject osteoarthritis . Following 2-week screening period , approximately 45 subject randomly assign one follow two arm 2:1 ratio ( 2 JointStem : 1 positive control ) . After last subject complete 6-month visit ( Visit 6 ) data management team confirm data issue , database lock blind open statistical analysis . Subjects schedule 9-month 12-month follow-up visit ( Visits 7 8 ) .</brief_summary>
	<brief_title>A Phase 2 Study Evaluate Efficacy Safety JointStem Treatment Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Subject give write informed consent Male female race , aged 2260 Subject osteoarthritis knee diagnose least six month prior Screening Subject joint pain ≥ 40mm VAS ( Visual Analog Scale ) Screening Subject swelling , tenderness active range motion ≥ Grade I Screening Subject seek invasive intervention intraarticular injection Subject willing discontinue pain medication osteoarthritis except rescue medication ( &lt; acetaminophen 3.25 g per day ) least 72 hour prior screen throughout duration study Subject radiographic evidence grade 3 4 osteoarthritis base Kellgren Lawrence radiographic criterion . Female subject neither pregnant lactating Subject able comply lifestyle guideline , schedule visit , treatment plan , laboratory test , study procedure Subject Body Mass Index ( BMI ) &gt; 35 kg/m2 Subject unstable knee Subject take NSAID within two week Screening Subject intraarticular injection therapy joint within 2 month Screening Subject clinically significant disease , judge investigator affect clinical trial Subject inflammatory arthropathy ( rheumatoid , psoriatic , avascular necrosis ) , post traumatic septic arthritis Subject chondrocalcinosis , Paget 's disease , Villonodular synovitis , nonOA joint disease Subject HIV/viral hepatitis Subject knee surgery radiation therapy affect joint within 6 month Screening Subject CVA attack within 6 month Screening Subject investigator judge liposuction cause problem Subject significant lab abnormality Subject history local anesthetic allergy Subject take immunosuppressant Cyclosporin A azathioprine within 6 week Screening ( If subject use aspirin plavix ) Subject determine would safe stop aspirin/plavix therapy 2 week prior Visit 2 Subject use anticoagulant stop correct Subject oral intramuscular corticosteroid within 30 day Visit 2 Subject intraarticular corticosteroid injection joint within 30 day Visit 2 Subject intraarticular hyaluronic acid injection within 30 day Visit 2 Subject know hypersensitivity ( allergy ) hyaluronan ( sodium hyaluronate ) preparation gram positive protein Subject knee joint infection skin disease infection area injection site Subject know systemic bleeding disorder Subject active drug/EtOH abuser Subject enrol clinical trial within 2 month Screening Subject principal investigator considers inappropriate study due reason list Subject whose MRI scan result screen demonstrate sign cartilage damage</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>